Chemoinformaics analysis of (+)-11-Isolupanine
| Molecular Weight | 248.37 | nRot | 0 |
| Heavy Atom Molecular Weight | 224.178 | nRig | 21 |
| Exact Molecular Weight | 248.189 | nRing | 4 |
| Solubility: LogS | -1.19 | nHRing | 4 |
| Solubility: LogP | 0.525 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 4 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 4 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 44.055 |
| nHD | 0 | BPOL | 28.365 |
| QED | 0.653 |
| Synth | 4.359 |
| Natural Product Likeliness | 0.932 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.991 |
| HIA | 0.013 |
| CACO-2 | -5.079 |
| MDCK | 0.00000936 |
| BBB | 0.634 |
| PPB | 0.145402 |
| VDSS | 1.517 |
| FU | 0.806161 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.097 |
| CYP2c19-inh | 0.048 |
| CYP2c19-sub | 0.741 |
| CYP2c9-inh | 0.008 |
| CYP2c9-sub | 0.073 |
| CYP2d6-inh | 0.622 |
| CYP2d6-sub | 0.58 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.381 |
| CL | 11.48 |
| T12 | 0.395 |
| hERG | 0.154 |
| Ames | 0.009 |
| ROA | 0.019 |
| SkinSen | 0.957 |
| Carcinogencity | 0.597 |
| EI | 0.311 |
| Respiratory | 0.908 |
| NR-Aromatase | 0.027 |
| Antiviral | Yes |
| Prediction | 0.789944 |